Petra Kroll
About Petra Kroll
Petra Kroll is the Senior Manager of Site Management/Trial Operations at Boston Scientific with extensive experience in clinical research operations across Europe.
Current Role at Boston Scientific
Petra Kroll currently serves as the Senior Manager of Site Management and Trial Operations at Boston Scientific. She has been with the company since 2015, bringing her extensive experience in managing clinical research operations to her role. At Boston Scientific, Petra is responsible for overseeing and managing Contract Research Organizations (CROs) in Europe and Australia/New Zealand, ensuring the smooth operation of clinical trials.
Past Experience at Chiltern International
Prior to her current role, Petra Kroll worked at Chiltern International as a Senior Line Manager and Regional Area Manager from 2012 to 2015. During her three years there, she managed line teams of up to 25 people in various European countries. Petra played a pivotal role in organizing and maintaining the Functional Service Provider (FSP) model in Poland, contributing significantly to the company's operations.
Earlier Roles and Responsibilities
Before joining Chiltern International, Petra Kroll held several key positions in the clinical research field. She worked at PRA Health Sciences as a Senior Clinical Team Manager from 2011 to 2012, managing trials and clinical teams. Additionally, she served as Manager CRS at Amgen for 5 months in 2011. These roles further honed her skills in clinical trial management and team leadership.
Educational Background
Petra Kroll studied at FAS Hannover, where she completed a Bachelor of Science degree as a Teacher for Medical Professionals from 1994 to 1995. Her education provided her with a strong foundation in medical and clinical research, which she has built upon throughout her career in various managerial positions within the clinical research industry.
Expertise in Clinical Research
With an extensive background in managing clinical research operations, Petra Kroll has been involved in all phases of clinical trials, from study start-up to close-out. She has particularly deep expertise in the fields of oncology and haematology. Her role has often included overseeing and managing CROs, ensuring compliance and efficacy in clinical trial processes across multiple European countries and regions like Australia/New Zealand.